About Time BioVentures
Time BioVentures is a venture capital firm founded in 2020. It is primarily based out of California City, United States. As of Jul 2026, Time BioVentures is an active investor, having invested in 13 companies, with 2 new investments in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and HealthTech. Most recently it participated in the $***** Series D round of AdvanCell Overall, Time BioVentures portfolio has seen 2 unicorns and 1 IPO, namely BillionToOne, Neuralink and Iterative Health. A lot of funds co-invest with Time BioVentures, with names like Cadence Healthcare Ventures sharing a substantial percentage of its portfolio. Time BioVentures has team of 13 people including 2 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series C & 2 more
Portfolio IPOs
Portfolio Unicorns
Portfolio Soonicorns
Time BioVentures' List of Top Investments
Time BioVentures has a portfolio of 13 companies, including 2 unicorns. Their most notable investments are in BillionToOne and Phantom.Their portfolio spans across United States, Australia and Netherlands. They have invested in Life Sciences, High Tech, HealthTech and 3 other sectors, across stages such as Series A, Series C and 2 more. Here is the list of top investments by Time BioVentures:1. BillionToOne
Provider of cell-free cancer liquid biopsy test. The company provides a molecular counter platform to count the DNA molecules from blood samples. It provides genetic tests for cystic fibrosis, spinal muscular atrophy, sickle cell disease, etc.
Key facts about BillionToOne
- Founded Year: 2015
- Location: San Francisco (United States)
- Stage: Public
- Total Funding till date: $389M
- Employee Count: 787 as on May 31, 2026
- Investors: Adams Street Partners, Oberland Capital and 31 Others
- Latest Funding Round: Series D, Jun 21, 2024, $*****
- Highlight: Public
2. Neuralink
Provider of implantable brain-computer interfaces. It offers flagship product the N1 Implant the Link which is a coin-sized device designed to decode neural signals and enable users to control digital devices using only their thoughts. It also has an experimental device called Blindsight to restore vision in individuals with optic nerve damage by directly stimulating the visual cortex.
Key facts about Neuralink
- Founded Year: 2016
- Location: Fremont (United States)
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $1.29B
- Employee Count: 675 as on May 31, 2026
- Investors: Google Ventures, ARK Investment Management and 37 Others
- Latest Funding Round: Series E, May 08, 2026, $*****
- Highlight: Editors' Pick
3. AdvanCell
Radiopharmaceutical company developing targeted alpha therapies for cancer treatment. The company involves a proprietary ²¹²Pb production technology that provides access to alpha isotopes to accelerate the clinical development of drugs for prostate, skin, pancreatic, breast, bladder, colorectal, kidney, lung, and ovary cancer.
Key facts about AdvanCell
- Founded Year: 2019
- Location: Brisbane (Australia)
- Stage: Series D
- Total Funding till date: $444M
- Employee Count: 85 as on May 31, 2026
- Investors: T. Rowe Price, Bain Capital Life Sciences and 18 Others
- Latest Funding Round: Series D, Jul 15, 2026, $*****
- Highlight: Editors' Pick
Virtual mental healthcare platform. It offers personalized virtual therapy and treatment for adults and teens dealing with a range of conditions including anxiety, depression, PTSD, OCD, insomnia, bipolar disorder, and others.
Key facts about Brightside Health
- Founded Year: 2017
- Location: San Francisco (United States)
- Stage: Series C
- Total Funding till date: $114M
- Employee Count: 476 as on May 31, 2026
- Investors: Bullpen Capital, Mousse Partners and 13 Others
- Latest Funding Round: Series C, Mar 26, 2024, $*****
- Highlight: Editors' Pick
5. Waypoint
Key facts about Waypoint
- Founded Year: 2021
- Location: New York City (United States)
- Stage: Series A
- Total Funding till date: $34.5M
- Employee Count: 20 as on May 31, 2026
- Investors: General Catalyst, Amplify Partners and 7 Others
- Latest Funding Round: Series A, Jun 01, 2026, $*****
- Highlight: Editors' Pick
Time BioVentures' Year-on-Year Investment Trends
Time BioVentures has invested in 13 companies over the last 6 years, with an average of 2 new investments annually in the last 5 years. In 2025, it made 3 investments, while as of Jul 2026, it has made 2 investments in this year. Its most recent first time investment was in AdvanCell and most recent follow-on round was in Phantom.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 2 | 0 | 2 |
2025 | 1 | 2 | 3 |
2024 | 2 | 0 | 2 |
2023 | 1 | 0 | 1 |
2022 | 2 | 1 | 3 |
2021 | 2 | 0 | 2 |
2020 | 1 | 0 | 1 |
Time BioVentures' Investments by Stage
Time BioVentures has made 5 investments in Series A stage with an average round size of $26.7M, 3 investments in Series C stage with an average round size of $62.7M, 2 investments in Seed stage with an average round size of $9.76M and 1 investment in Series D stage with an average round size of $315M.Stage of entry | No. of Investments |
|---|---|
Series A | 5 |
Series C | 3 |
Seed | 2 |
Series D | 1 |
Note: We have considered here, only first round of investments
Time BioVentures' Investments by Sector
Time BioVentures has a diverse portfolio, with companies operating in the Life Sciences, HealthTech, Healthcare, Enterprise Applications and Consumer. Notably, it has invested in 10 Tech companies, 8 Enterprise (B2B) companies, 5 Tech hardware companies and at least 4 companies focusing on Software.Sector | No. of Investments |
|---|---|
Life Sciences | 6 |
HealthTech | 3 |
Healthcare | 3 |
Enterprise Applications | 2 |
Consumer | 1 |
Others | 3 |
Note: We have considered here, only first round of investments
Time BioVentures' Investments by Geography
Time BioVentures has made most investments in United States (11), followed by Australia where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 11 |
Australia | 1 |
Note: We have considered here, only first round of investments
Time BioVentures' recent investments
Time BioVentures has made 2 investments in 2026 so far - AdvanCell and Waypoint.Here are the most recent investments by Time BioVentures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jul 15, 2026 | Australia | Series D | 8045 | [+17] | |
Jun 01, 2026 | United States | Series A | 4455 | [+4] | |
Mar 07, 2025 | United States | Series A | 4597 | [+10] | |
Jan 27, 2025 | United States | Series B | 7181 | ||
Jan 14, 2025 | United States | Series A | 5328 | [+8] |
Unicorns in Time BioVentures' Portfolio
Time BioVentures has 2 unicorns in its portfolio - Iterative Health and Neuralink. The most recent unicorn in their portfolio is Iterative Health. It became a unicorn in 2026, 6 years after Time BioVentures first invested in it.Here is a list of unicorns in Time BioVentures' portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
60 | Provider of AI-based device for endoscopic images of gastroenterological diseases | 2017 | Cambridge | Series C | uceasex | ||
66 | Provider of implantable brain-computer interfaces | 2016 | Fremont | Series E | huzowex |
IPOs and Publicly Listed companies in Time BioVentures' Portfolio
1 of Time BioVentures' portfolio company became public - BillionToOne. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Nov 2025 at marketcap of $2.41BHere are Time BioVentures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Nov 06, 2025 | Mar 30, 2022 | Series C | 1940 |
Team profile of Time BioVentures
Time BioVentures has a team of 13 members including 2 Partners located in United States and Puerto Rico. Time BioVentures' team does not sit on the board of any company as of now.Co-investors of Time BioVentures
Over the past 6 years, 114 investors have co-invested in Time BioVentures's portfolio companies. This includes funds and angels.
- Invested before Time BioVentures: Hummingbird Ventures, Fifty Years and 37 others have invested in rounds before Time BioVentures. There are 2 companies where Hummingbird Ventures has invested before Time BioVentures and 2 companies where Fifty Years has invested before Time BioVentures.
- Top Co-investors of Time BioVentures: 48 investors entered a company along with Time BioVentures. These include investors like Cadence Healthcare Ventures (2 companies).
- Invested after Time BioVentures: A total of 27 investors have invested in Time BioVentures's portfolio after their investments. Top Investors include Bridge Community Bank (1 company), Premji Invest (1 company) and Neuberger Berman (1 company).
Recent News related to Time BioVentures
•
Twenty Raises $100M in Series B Funding, at $1 Billion ValuationFinSMEs•Jun 17, 2026•In-Q-Tel, General Catalyst, Caffeinated Capital, Waypoint and 7 others
•
Waypoint Bio Raises $20M Series A Led by Amplify Partners to Advance AI-Designed Cell Therapies Toward the ClinicBusiness Wire•Jun 01, 2026•Waypoint, Amplify Partners, Amplify, Time BioVentures and 4 others
•
Conceivable Life Sciences Closes $18M Series A FinancingFinSMEs•Jan 15, 2025•Conceivable, Artis Ventures, Atlantic Health System, Muse Capital and 7 others
•
•
Brightside Health Secures $33M to Expand Access to Mental HealthcareHIT Consultant•Mar 27, 2024•Brightside Health, S32, Time BioVentures, Kennedy Lewis Investment Management and 5 others
•
Commons Clinic Raises $19 MillionLos Angeles Business Journal•Oct 30, 2023•Commons Clinic, RA Capital Management, Floating Point, Courtside Ventures and 1 other
•
Commons Clinic Secures $19.5M for VBC Model for Spinal Care, Orthopedics, and Pain ManagementHIT Consultant•Oct 09, 2023•Commons Clinic, RA Capital Management, , Courtside Ventures and 2 others
•
Bridge Bank Increases BillionToOne’s Term Loan to $35MMABFJournal•Dec 19, 2022•BillionToOne, Western Alliance Bank, Libertus Capital, Hummingbird Ventures and 7 others
•
BillionToOne Secures Additional $48.5M; Up To $35M Term Loan FacilityApkaHindiBlog•Dec 19, 2022•Time BioVentures, , Fifty Years, Neotribe and 9 others
•
BillionToOne Secures $83.5M in Capital, Upsized Loan Facility; Shows Clinical Performance of NIPTGenomeWeb•Dec 15, 2022•BillionToOne, Libertus Capital, Hummingbird Ventures, Baillie Gifford and 5 others
